FOLFIRI-BEVACIZUMAB

Placeholder slot

(... beh-vuh-SIH-zoo-mab)

This combination contains the chemotherapy drugs leucovorin calcium (folinic acid), fluorouracil, and irinotecan hydrochloride and the targeted therapy drug bevacizumab. Combinations usually work better than single drugs because different drugs kill cancer cells in different ways.

Drugs in the FOLFIRI-BEVACIZUMAB combination:
FOL	= Leucovorin Calcium (Folinic Acid)
F	= Fluorouracil
IRI	= Irinotecan Hydrochloride
	+ Bevacizumab

Each of the drugs in this combination is approved by the Food and Drug Administration (FDA) to treat cancer or conditions related to cancer.

Use in Cancer

FOLFIRI-BEVACIZUMAB is used to treat:

Colorectal cancer that has metastasized (spread to other parts of the body).

This combination may also be used with other drugs or treatments or to treat other types of cancer.

More About FOLFIRI-BEVACIZUMAB

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.